Sibley K - Search Results

1

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT. Randerson-Moor JA, et al. Among authors: sibley k. Hum Mol Genet. 2001 Jan 1;10(1):55-62. doi: 10.1093/hmg/10.1.55. Hum Mol Genet. 2001. PMID: 11136714

2

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.

Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. Williams SV, et al. Genes Chromosomes Cancer. 2002 May;34(1):86-96. doi: 10.1002/gcc.10050. Genes Chromosomes Cancer. 2002. PMID: 11921286

3

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

Sibley K, Cuthbert-Heavens D, Knowles MA. Sibley K, et al. Oncogene. 2001 Feb 8;20(6):686-91. doi: 10.1038/sj.onc.1204110. Oncogene. 2001. PMID: 11314002

4

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

Sibley K, Stern P, Knowles MA. Sibley K, et al. Oncogene. 2001 Jul 19;20(32):4416-8. doi: 10.1038/sj.onc.1204543. Oncogene. 2001. PMID: 11466624

5

Redefining a critical region of LOH on 4p16.3 in bladder cancer.

Sibley K, Bell S, Knowles MA. Sibley K, et al. Genes Chromosomes Cancer. 2000 Dec;29(4):378-9. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1045>3.0.co;2-k. Genes Chromosomes Cancer. 2000. PMID: 11066086 No abstract available.

6

Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.

Fenton JA, Pratt G, Rawstron AC, Sibley K, Rothwell D, Yates Z, Dring A, Richards SJ, Ashcroft AJ, Davies FE, Owen RG, Child JA, Morgan GJ. Fenton JA, et al. Among authors: sibley k. Oncogene. 2003 Feb 20;22(7):1103-13. doi: 10.1038/sj.onc.1206335. Oncogene. 2003. PMID: 12592397

7

A molecular study of the t(4;14) in multiple myeloma.

Sibley K, Fenton JA, Dring AM, Ashcroft AJ, Rawstron AC, Morgan GJ. Sibley K, et al. Br J Haematol. 2002 Aug;118(2):514-20. doi: 10.1046/j.1365-2141.2002.03618.x. Br J Haematol. 2002. PMID: 12139740 Free article.

8

High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia.

Rollinson S, Allan JM, Law GR, Roddam PL, Smith MT, Skibola C, Smith AG, Forrest MS, Sibley K, Higuchi R, Germer S, Morgan GJ. Rollinson S, et al. Among authors: sibley k. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):795-800. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159312

9

Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, Skibola CF, Smith MT, Morgan GJ. Sibley K, et al. Cancer Res. 2003 Aug 1;63(15):4327-30. Cancer Res. 2003. PMID: 12907599

10

Factors influencing older adult community fall prevention exercise implementation: a scoping review.

Sibley KM, Tittlemier B, Olarinde F, Leadbetter BK, Bouchard DR. Sibley KM, et al. Age Ageing. 2024 Aug 6;53(8):afae186. doi: 10.1093/ageing/afae186. Age Ageing. 2024. PMID: 39171387 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters